Prenetics Completes $72 Million Sale of ACT, Strengthening Cash and Bitcoin Reserves
-
最新报道：According to Bijie.com and ME News, on October 8 (UTC+8), Prenetics (NASDAQ: PRE) announced the completion of the sale of ACT Genomics Co., Ltd. ("ACT") to Delta Electronics (TWSE: 2308) for US$72 million. This marks Prenetics' official exit from the clinical diagnostics sector, focusing on consumer healthcare. The company generated approximately US$46 million in revenue and has over US$60 million in cash reserves (excluding BTC), maintaining a debt-free balance sheet. This will provide funding for the continued development of its core brand, IM8. Prenetics also disclosed holdings of 255 BTC, with a market value of US$31.6 million. Since August, it has implemented a "one BTC per day" strategy, with all assets held on Kraken.
下一篇
Anthropic and IBM announce strategic partnership
- IBM is integrating Anthropic's Claude large language models into its software products, st...
24小时热点
热点专题
418154